OncoSec Medical Incorporated (OncoSec) (NASDAQ:ONCS), a company developing intratumoral cancer immunotherapies, today announced that Daniel J. O’Connor, President and Chief Executive Officer of OncoSec, will present at the Piper Jaffray 30th Annual Healthcare
November 20, 2018
· 1 min read